Biotech China 2014
Pulmonary Hypertension Summit
InterContinental Hotel and Bank of America Conference Center
9801 Carnegie Avenue Cleveland, OH 44106
Cleveland, OHIO
http://www.clevelandclinicmeded.com/live/courses/2011/PulHyper11/default.asp#ccfaculty
The Pulmonary Hypertension Summit 2011 is designed to bring together leaders in the field of pulmonary hypertension to discuss recent advances and future directions in the diagnosis and management of this disease.

The Summit will highlight disease mechanisms and pathophysiology of pulmonary hypertension as well as the evaluation and medical management of the patient with pulmonary hypertension.

Expert speakers will present the recent advances in the context of challenges faced by physicians and other health care providers caring for patients with this complex medical condition. 

The Summit is directed to physicians, physician assistants, and nurses with an interest in pulmonary disorders, rheumatologic diseases, and cardiovascular diseases. The case-based and practical approach of the sessions will make this extremely relevant for internal medicine and primary care physicians.

After completing these learning activities, the participant will be able to do the following:

    * Describe advances in the management of pulmonary hypertension;
    * Determine when to suspect pulmonary hypertension and how to diagnose it;
    * Explain the current approach of diagnosing pulmonary hypertension in the presence of     associated             or underlying diseases;
    * Create a case-based approach to the practical aspects of pulmonary hypertension           management.

Submission Deadline:  October 15, 2011     
Notification to submitting authors: October 20, 2011

Abstract Awards
Best abstracts will be selected for oral presentations. The top three will be reimbursed for 2011 Summit registration and hotel accommodations. First place abstract will also receive a $500 cash prize.

Review Process
Abstracts will be reviewed for compliance with the instructions then assigned a number to ensure anonymity. Each abstract/poster is reviewed by the organizing committee for quality and content. Submitting authors of selected abstracts/posters will be notified of acceptance via email. Authors must be present at their posters during the assigned sessions(s) to talk with Summit participants.

Registration
Authors of accepted abstracts must register for the Summit. If you need a formal acceptance letter for visa, contact Darcy Lange at 216.448.0787.

General Abstract/Poster Information
Authors may submit abstracts/posters of completed work, work in progress, or work presented at a local or regional level. Abstracts presented elsewhere within the 12 months prior to the submission deadline will be accepted. The primary author is responsible for obtaining written consent from all authors and appropriate institutions prior to submitting an abstract/poster.

Abstracts/posters must be free of commercial bias. In addition, they may not imply an endorsement of any service by their institution or the Cleveland Clinic.

All research papers submitted must be formatted according to guidelines.  

Abstract/Poster Submission:
Please email your completed abstract and forms to Darcy Lange at langed@ccf.org. If your submission is larger than 10 MB, please call Darcy for further instructions. Submissions by fax or mail are not permitted.  Upon abstract/poster acceptance, submitting author will be notified.

Official Language
Papers must be submitted and presented in English.

Author Affiliation
Authors from different institutions should be identified by a numeral within the process.

Text of the Abstract/Poster
A. Text, including headings, may not exceed 2 letter size (8 ½� x 11�) pages.  Please use 11-point Arial font.

B. The use of standard abbreviations is acceptable. Other abbreviations should be placed in parentheses, after the first appearance of the full word(s) for which it stands.

C. Topic: Abstracts/posters must relate to Pulmonary Hypertension.  

To submit, please email your completed abstract and forms to Darcy Lange at langed@ccf.org. If your submission is larger than 10 MB, please call Darcy for further instructions. 

http://www.clevelandclinicmeded.com/live/courses/2011/PulHyper11/default.asp#ccfaculty

Schedule of Presentations:

Sunday, November 6, 2011
12:00:00 Lunch | Registration | Exhibits
12:55:00 Patient-Oriented Sessions Gustavo A. A. Heresi, Adrienne Dern
13:00:00 How Do We Diagnose Pulmonary Hypertension (PH)? Adriano Tonelli
13:20:00 You Have Been Diagnosed with PH: What Next?
13:50:00 How Do We Choose Therapies: Oral, Inhaled, IV? Joseph G. Parambil
14:10:00 Oxygen and Travel Scott A. Marlow
14:30:00 Refreshments Break | Exhibits
14:45:00 Exercise and Rehab Loutfi S. Aboussouan
15:05:00 Achieving Balance and Emotional Well-Being for the Patient and Caregiver
15:30:00 Pulmonary Hypertension | Focus on Research Katie Zak, Weiling Xu, Jennie Newman, Diane Fabec, Suzy A. Comhair, Metin Aytekin, Micheala A. Aldred
15:50:00 Ask the Experts | Anything Goes Adriano Tonelli, Joseph G. Parambil, Omar A. Minai, Raed Dweik
16:10:00 Closing Remarks Gustavo A. A. Heresi
16:15:00 Adjourn
16:20:00 OPTIONAL tour of genetic lab (Non-CME) Micheala A. Aldred
Monday, November 7, 2011
07:00:00 Registration | Continental Breakfast | Exhibits
07:45:00 Opening Remarks
07:55:00 Survival in Pulmonary Arterial Hypertension (PAH) | Where Are We Now? Raed Dweik
08:00:00 Determinants of Survival in PAH | What Does REVEAL Reveal? Raymond L. Benza
08:40:00 Indicators of Survival in PAH: Lessons from the French National Registry Olivier Sitbon
09:20:00 Determinants of Survival in PAH | Take Home Messages Omar A. Minai
09:50:00 Panel Discussion | Questions and Answers Olivier Sitbon, Omar A. Minai, Raed Dweik, Raymond L. Benza
10:00:00 Refreshments | Exhibits
10:10:00 Strategies to Improve Survival in PH | The Way Forward Gustavo A. A. Heresi
10:15:00 Early Detection and Improved Monitoring can Improve Survival Ronald J. Oudiz
10:50:00 Surviving Critical Illness in Pulmonary Hypertension Raed Dweik
11:30:00 New Therapeutic Options on the Horizon Will Improve Survival in PH Stephen L. Archer
12:10:00 Panel Discussion Ronald J. Oudiz, Raed Dweik, Raymond L. Benza, Stephen L. Archer
12:30:00 Lunch
13:25:00 PH Management | Back to Basics Adriano Tonelli
13:30:00 Making the Diagnosis of PH | The Algorithm and Avoiding the Pitfalls Adriano Tonelli
14:00:00 Pulmonary Hypertension in Scleroderma | Similarities and Differences Joseph G. Parambil
14:30:00 Update on Diasgnosis and Treatment Guidelines in PAH Gustavo A. A. Heresi
15:00:00 Refreshments | Exhibits | Posters
15:15:00 Panel Discussion | Interesting Cases Omar A. Minai
15:25:00 Case Presenters
15:30:00 Panel Adriano Tonelli, Olivier Sitbon, Joseph G. Parambil, Ronald J. Oudiz, Gustavo A. A. Heresi, Raymond L. Benza, Stephen L. Archer
17:00:00 Adjourn
Tuesday, November 8, 2011
07:00:00 Registration | Continental Breakfast | Exhibits
07:45:00 Opening Remark Gustavo A. A. Heresi
07:55:00 Interventional and Surgical Therapies for Pulmonary Hypertension Gustavo A. A. Heresi
08:00:00 Pulmonary Embolism Jerry Bartholomew
08:30:00 Chronic Thromboembolic Pulmonary Hypertension
09:10:00 Pulmonary Thromboendarterectomy Nicholas G. Smedira
09:50:00 Current Role of Lung Transplantation in PH Marie Budev
10:20:00 Refreshments | Exhibits | Posters
10:40:00 Panel Discussion Nicholas G. Smedira, Gustavo A. A. Heresi, Marie Budev
11:10:00 Cardiac Issues in Pulmonary Hypertension Randall C. Starling
11:15:00 High RVSP | Right vs Left David O. Taylor
11:45:00 PH in Congenital Heart Disease Richard Krasuski
12:15:00 Lunch
13:15:00 Oral Poster Presentations | Abstracts Raed Dweik
13:20:00 Confirmed Presenters Samar Farha, Kewal Asosingh, Metin Aytekin, Micheala A. Aldred
15:00:00 Refreshments | Exhibits | Posters
15:15:00 Oral Presentations by Nominees for Abstract Awards Adriano Tonelli, Gustavo A. A. Heresi
15:20:00 Presentors
17:00:00 Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.